JP2019515880A5 - - Google Patents

Download PDF

Info

Publication number
JP2019515880A5
JP2019515880A5 JP2018549266A JP2018549266A JP2019515880A5 JP 2019515880 A5 JP2019515880 A5 JP 2019515880A5 JP 2018549266 A JP2018549266 A JP 2018549266A JP 2018549266 A JP2018549266 A JP 2018549266A JP 2019515880 A5 JP2019515880 A5 JP 2019515880A5
Authority
JP
Japan
Prior art keywords
alkyl
alkynyl
alkenyl
group
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018549266A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019515880A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/022755 external-priority patent/WO2017161144A1/en
Publication of JP2019515880A publication Critical patent/JP2019515880A/ja
Publication of JP2019515880A5 publication Critical patent/JP2019515880A5/ja
Pending legal-status Critical Current

Links

JP2018549266A 2016-03-16 2017-03-16 炭酸無水酵素ｉｘ阻害剤抱合体およびその使用 Pending JP2019515880A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662309271P 2016-03-16 2016-03-16
US62/309,271 2016-03-16
PCT/US2017/022755 WO2017161144A1 (en) 2016-03-16 2017-03-16 Carbonic anhydrase ix inhibitor conjugates and uses thereof

Publications (2)

Publication Number Publication Date
JP2019515880A JP2019515880A (ja) 2019-06-13
JP2019515880A5 true JP2019515880A5 (enExample) 2020-04-23

Family

ID=59852036

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018549266A Pending JP2019515880A (ja) 2016-03-16 2017-03-16 炭酸無水酵素ｉｘ阻害剤抱合体およびその使用

Country Status (5)

Country Link
US (1) US10857234B2 (enExample)
EP (1) EP3429637A4 (enExample)
JP (1) JP2019515880A (enExample)
CA (1) CA3017211A1 (enExample)
WO (1) WO2017161144A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3429575A4 (en) * 2016-03-16 2019-10-23 Purdue Research Foundation AGAINST CARBOANHYDRASE-IX DRUGS AND METHODS
CN112312901B (zh) 2018-05-10 2024-05-14 路易斯维尔大学研究基金会有限公司 Ras癌蛋白抑制剂及其制备方法和使用方法
KR20240069480A (ko) * 2022-11-11 2024-05-20 울산과학기술원 자가조립 가능한 펩타이드 분자를 포함하는 양친매성 접합체 및 이의 용도
JP2025537882A (ja) * 2022-11-17 2025-11-20 ハンス－ゲオルク レルケン 腫瘍微小環境において切断可能な小分子－薬物コンジュゲート
WO2025044924A1 (zh) * 2023-08-25 2025-03-06 无锡诺宇医药科技有限公司 靶向碳酸酐酶放射性药物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258401B1 (en) 2002-05-06 2014-07-09 Endocyte, Inc. Folate-receptor targeted imaging agents
EP2374480A3 (en) * 2005-08-19 2013-05-01 Endocyte, Inc. Mutli-drug ligand conjugates
US20090043099A1 (en) 2006-03-17 2009-02-12 The Burnham Institute Methods and compositions for derepression of IAP-inhibited caspase
US20100104626A1 (en) * 2007-02-16 2010-04-29 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
CN104383553A (zh) * 2007-06-25 2015-03-04 恩多塞特公司 含有亲水性间隔区接头的共轭物
US9193763B2 (en) 2007-08-17 2015-11-24 Purdue Research Foundation PSMA binding ligand-linker conjugates and methods for using
AU2009204133B2 (en) * 2008-01-09 2014-04-10 Molecular Insight Pharmaceuticals, Inc. Inhibitors of carbonic anhydrase IX
WO2010087994A2 (en) 2009-01-30 2010-08-05 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
CN101596433B (zh) 2009-07-15 2011-07-06 中国科学院工程热物理研究所 U形返料器的冷却式隔板
FR2951449B1 (fr) 2009-10-15 2011-11-25 Commissariat Energie Atomique Procede de fonctionnalisation de molecules biologiques
WO2011090710A2 (en) 2009-12-28 2011-07-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Composite probes and use thereof in super resolution methods
US20130053392A1 (en) 2010-02-12 2013-02-28 Peter Ebbesen Carbonic anhydrase inhibitors
JP5544239B2 (ja) 2010-07-29 2014-07-09 富士フイルム株式会社 重合性組成物
CA2835286C (en) * 2011-05-09 2021-03-23 Visen Medical, Inc. Carbonic anhydrase targeting agents and methods of using same
DK2766364T3 (da) 2011-08-17 2024-09-30 Merck & Cie Folatkonjugater af albumin-bindende enheder
US20140249315A1 (en) * 2013-03-01 2014-09-04 Endocyte, Inc. Processes for preparing tubulysins
ES2843537T3 (es) 2014-01-28 2021-07-19 Tube Pharmaceuticals Gmbh Compuestos citotóxicos de tubulisina y conjugados de los mismos
US9771380B2 (en) 2014-06-09 2017-09-26 University Of Oregon Gold nanoparticles and methods of making and using gold nanoparticles
EP3429575A4 (en) * 2016-03-16 2019-10-23 Purdue Research Foundation AGAINST CARBOANHYDRASE-IX DRUGS AND METHODS
US12144850B2 (en) * 2016-04-08 2024-11-19 Purdue Research Foundation Methods and compositions for car T cell therapy

Similar Documents

Publication Publication Date Title
JP2020502130A5 (enExample)
ES2972577T3 (es) Formación de imágenes y terapia dirigidas a la proteína de activación de fibroblastos (FAP)
CN104955485B (zh) 吡咯并苯并二氮杂卓‑抗her2抗体结合物
CN105102003B (zh) 吡咯并苯并二氮杂卓-抗psma抗体结合物
CN105102068B (zh) 吡咯并苯并二氮杂卓-抗体结合物
CN105050661B (zh) 吡咯并苯并二氮杂卓‑抗体结合物
JP2025066807A (ja) 生体直交型組成物
ES2815098T3 (es) Conjugados de ligadores (ADCs) con inhibidores de KSP
CN108093640B (zh) 位点特异性抗体-药物缀合物
RU2018119683A (ru) Сайт-специфические конъюгаты антитела к her2 и лекарственного средства
ES2755101T3 (es) Nuevos compuestos y conjugados de criptoficina, su preparación y su uso terapéutico
CN105102004A (zh) 吡咯并苯并二氮杂卓-抗cd22抗体结合物
RU2003137593A (ru) Соединения на основе пептидов для направленной доставки к рецепторам интегринов
JP2020502131A5 (enExample)
JP7184775B2 (ja) 黄体化ホルモン放出ホルモン受容体（ｌｈｒｈ－ｒ）コンジュゲートおよびその使用
JP2016528251A5 (enExample)
CN107683146A (zh) 位点特异性抗体‑药物缀合物
CA2976811A1 (en) Solid dispersions of ospemifene
CN111225688B (zh) 靶向碳酸酐酶阳性癌症的基于fbsa的治疗和放射性成像缀合物
JP2020534300A5 (enExample)
CN113473975A (zh) 制备官能化环辛烯的工艺
JP2021521172A (ja) 抗腫瘍剤としてのピロロベンゾジアゼピン及びその複合体
JP2019512511A5 (enExample)
JP2019515880A (ja) 炭酸無水酵素ｉｘ阻害剤抱合体およびその使用
JP2026502604A (ja) エリブリン系薬物の複合体